| AmBisome (liposomal amphotericin B) | IV route - Restricted to ID or Antimicrobial Stewardship except: 1) Prophylaxis against fungal infections in patients on the HBC (Hematology, Blood & Marrow Transplant, and Cellular Therapy) service
|
| Amikacin | Restricted to ID or Antimicrobial Stewardship for IV amikacin |
| Artesunate | Restricted to ID or Antimicrobial Stewardship |
| Aztreonam | Restricted to ID or Antimicrobial Stewardship |
| Aztreonam/avibactam | Restricted to ID or Antimicrobial Stewardship |
| Baloxavir marboxil | Restricted to ID or Antimicrobial Stewardship |
| Cefiderocol | Restricted to ID or Antimicrobial Stewardship |
| Ceftaroline | Restricted to ID or Antimicrobial Stewardship |
| Ceftazidime/avibactam (Avycaz) | Restricted to ID or Antimicrobial Stewardship |
| Ceftolozane/tazobactam (Zerbaxa) | Restricted to ID or Antimicrobial Stewardship |
| Cidofovir | Restrict to ID or Antimicrobial Stewardship except: 1) For treatment or prophylaxis against viral infection in HBC patients |
| Colistin IV | Restricted to ID or Antimicrobial Stewardship *Inhaled use of colistin is allowed for unrestricted use in prophylaxis in lung transplant. |
| Dalbavancin | Restricted to ID or Antimicrobial Stewardship |
| Daptomycin | Restricted to ID or Antimicrobial Stewardship |
| Eravacycline | Restricted to ID or Antimicrobial Stewardship ZSFG: Non-formulary |
| Fecal microbiota spores, live—brpk (Vowst) | Restricted to ID/ASP for use in select adults with recurrent CDI who are expected to be hospitalized > 14 days after C. difficile episode. ZSFG: Non-formulary |
| Foscarnet | Restricted to ID or Antimicrobial Stewardship except: 1) For treatment or prophylaxis against viral infection in HBC patients |
| Fosfomycin IV (Contepo) | Restricted to ID or Antimicrobial Stewardship |
| Imipenem/cilastatin | Restricted to ID or Antimicrobial Stewardship |
| Imipenem/cilastatin/relebactam | Restricted to ID or Antimicrobial Stewardship |